Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Mineralys Therapeutics Inc (MLYS)

Mineralys Therapeutics Inc (MLYS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Mineralys Therapeutics Inc 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 USA

www.mineralystx.com Employees: 51 P: 888-378-6240

Sector:

Medical

Description:

Mineralys Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. Mineralys Therapeutics Inc. is based in RADNOR, Pa.

Key Statistics

Overview:

Market Capitalization, $K 2,852,205
Enterprise Value, $K 2,738,115
Shares Outstanding, K 79,140
Annual Sales, $ 0 K
Annual Net Income, $ -177,810 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -36,930 K
EBIT, $ -184,100 K
EBITDA, $ -184,060 K
60-Month Beta 0.40
% of Insider Shareholders 25.56%
% of Institutional Shareholders 84.46%
Float, K 58,912
% Float 74.44%
Short Interest 7,406
Short Float 9.36%
Short Volume Ratio 0.37

Growth:

1-Year Return 199.76%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.52 on 11/10/25
Next Earnings Date 02/11/26
Earnings Per Share ttm -2.95
EPS Growth vs. Prev Qtr 21.21%
EPS Growth vs. Prev Year 53.98%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

MLYS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -48.18%
Return-on-Assets % -45.80%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 4.14
Book Value/Share 8.69
Interest Coverage -6.46
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar